Net Income Increased
Fiscal Year 2026 Guidance for
First Quarter 2026 Highlights Compared to Prior Year Period
- Net sales were
$180 million , an increase of $49 million or 37%. Vita Coco Coconut Water net sales grew 42%.- Gross profit was $72 million, an increase of $24 million, and Gross margin was 40% of net sales compared to 37%.
- Net income was $30 million, an increase of $12 million, and Net income per diluted share was
$0.50 compared to$0.31 . - Non-GAAP Adjusted EBITDA1 was $39 million, an increase of
$16 million .
First Quarter 2026 Consolidated Results
Net sales increased $49 million, or 37%, to $180 million compared to $131 million in the prior year period. The increase in net sales was driven by case equivalent ("CE") volume gains of 32% for
Gross profit increased to $72 million, from $48 million in the prior year period driven by increased sales, higher pricing and lower ocean freight rates, partially offset by higher finished goods and domestic logistics costs as well as tariff-related costs associated with inventory sold during the period compared to the prior year period. Gross margin was 40% compared to 37% in the prior year period. The increase resulted from higher pricing and lower ocean freight rates, slightly offset by the impact of higher-cost inventory flowing through cost of goods sold.
Selling, general and administrative ("SG&A") expenses were $38 million, compared to $29 million in the prior year period. The increase was due to increased personnel expenses including performance-based stock compensation, investments in sales and marketing, and an increase in distributor related expenses.
Net income was $30 million, or
Non-GAAP Adjusted EBITDA1 was $39 million, compared to $23 million in the prior year due to the increased gross profit partially offset by higher SG&A expenses.
Balance Sheet
As of
On
Fiscal Year 2026 Full Year Outlook
The Company is increasing its full year 2026 guidance as follows:
- Net sales expected to be between
$720 million and$735 million , driven by mid-to-high teens growth ofVita Coco Coconut Water and improvements in Private Label trends from new and regained business. (Prior guidance was between$680 million and$700 million ). - Gross margin expected to be approximately 38% with benefit relative to prior year from lower cost of goods due to a reduction in tariffs and higher pricing partially offset by adverse product mix, inflationary impacts, and increased branded promotion and incentives. (Unchanged from prior guidance).
- SG&A expenses expected to increase high single digits versus 2025. (Prior guidance was mid to high single digit growth).
- Adjusted EBITDA1 expected to be in the range of
$132 million to$138 million . (Prior guidance was between$122 million and$128 million ).
Uncertainty and instability of the current operating environment, geopolitical landscape, and global economies, including the military conflict in
Footnotes
| (1) | Adjusted EBITDA represents earnings before interest, taxes, depreciation, and amortization as adjusted for certain items as set forth in the reconciliation table of |
| (2) | GAAP Net income 2026 outlook is not provided due to the inherent difficulty in quantifying certain amounts due to a variety of factors including the unpredictability in the movement in foreign currency rates, as well as future charges or reversals outside of the normal course of business. |
Conference Call and Webcast Details
To participate in the live earnings call and question and answer session, please register at https://register-conf.media-server.com/register/BIb3845c5985b34df9a4070549d644b276 and dial-in information will be provided directly to you. The live audio webcast will be accessible in the “Events” section of the Company’s Investor Relations website at https://investors.thevitacococompany.com/. An archived replay of the webcast will be available shortly after the live event has concluded.
About The
The
Contacts
Investor Relations:
investors@thevitacococompany.com
Non-GAAP Financial Measures
In addition to disclosing results determined in accordance with U.S. GAAP, the Company also discloses certain non-GAAP results of operations, including, but not limited to, Adjusted EBITDA, that include certain adjustments or exclude certain charges and gains that are described in the reconciliation table of U.S. GAAP to non-GAAP information provided at the end of this release. These non-GAAP measures are a key metric used by management and our board of directors to assess our financial performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance and because we believe it is useful for investors to see the measures that management uses to evaluate the Company. In addition, we believe the presentation of these measures is useful to investors for period-to-period comparisons of results as the items described below in the reconciliation tables do not reflect ongoing operating performance.
These measures are not in accordance with, or an alternative to, U.S. GAAP, and may be different from non-GAAP measures used by other companies. In addition, other companies, including companies in our industry, may calculate such measures differently, which reduces their usefulness as a comparative measure. Investors should not rely on any single financial measure when evaluating our business. This information should be considered as supplemental in nature and is not meant as a substitute for our operating results in accordance with U.S. GAAP. We recommend investors review the U.S. GAAP financial measures included in this earnings release. When viewed in conjunction with our U.S. GAAP results and the accompanying reconciliations, we believe these non-GAAP measures provide greater transparency and a more complete understanding of factors affecting our business than U.S. GAAP measures alone.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including but not limited to, statements regarding our future financial and operating performance, including our GAAP and non-GAAP guidance, our strategy, projected costs, tariffs, prospects, expectations, plans, objectives of management, supply chain predictions, customer and supplier relationships, and expected net sales and category share growth.
The forward-looking statements in this release are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond the Company’s control. These factors include, but are not limited to, those discussed under the caption “Risk Factors” in our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and our other filings with the U.S. Securities and Exchange Commission ("SEC") as such factors may be updated from time to time and which are accessible on the SEC’s website at www.sec.gov and the Investor Relations page of our website at https://investors.thevitacococompany.com. Any forward-looking statements contained in this press release speak only as of the date hereof and accordingly undue reliance should not be placed on such statements. We disclaim any obligation or undertaking to update or revise any forward-looking statements contained in this press release, whether as a result of new information, future events or otherwise, other than to the extent required by applicable law.
Website Disclosure
We intend to use our websites, vitacoco.com and investors.thevitacococompany.com, as a means for disclosing material non-public information and for complying with the
| THE CONDENSED CONSOLIDATED BALANCE SHEETS (Amounts in thousands, except share data) | |||||||
2026 | 2025 | ||||||
| Assets | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 201,912 | $ | 196,873 | |||
| Accounts receivable, net of allowance of | 120,840 | 81,514 | |||||
| Inventory | 86,412 | 111,468 | |||||
| Supplier advances, current | 626 | 693 | |||||
| Derivative assets | 2,963 | 732 | |||||
| Prepaid expenses and other current assets | 36,899 | 30,160 | |||||
| Total current assets | 449,652 | 421,440 | |||||
| Property and equipment, net | 9,276 | 9,298 | |||||
| 7,791 | 7,791 | ||||||
| Supplier advances, long-term | 1,779 | 1,860 | |||||
| Deferred tax assets, net | 6,465 | 6,463 | |||||
| Right-of-use assets, net | 10,943 | 11,592 | |||||
| Other assets | 2,437 | 2,714 | |||||
| Total assets | $ | 488,343 | $ | 461,158 | |||
| Liabilities and Stockholders’ Equity | |||||||
| Current liabilities: | |||||||
| Accounts payable | $ | 24,808 | $ | 25,464 | |||
| Accrued expenses and other current liabilities | 97,437 | 89,461 | |||||
| Derivative liabilities | 912 | 1,507 | |||||
| Total current liabilities | 123,157 | 116,432 | |||||
| Operating lease liability, long-term | 12,914 | 13,087 | |||||
| Other long-term liabilities | 99 | 97 | |||||
| Total liabilities | $ | 136,170 | $ | 129,616 | |||
| Stockholders’ equity: | |||||||
| Common stock, March 31, 2026 and March 31, 2026 and | 644 | 642 | |||||
| Additional paid-in capital | 187,520 | 185,400 | |||||
| Retained earnings | 258,488 | 228,014 | |||||
| Accumulated other comprehensive gain | 26 | 486 | |||||
| (94,505 | ) | (83,000 | ) | ||||
| Total stockholders’ equity | 352,173 | 331,542 | |||||
| Total liabilities and stockholders’ equity | $ | 488,343 | $ | 461,158 | |||
| THE CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Amounts in thousands, except for share and per share data) | ||||||
| Three Months Ended | ||||||
| 2026 | 2025 | |||||
| Net sales | $ | 179,765 | $ | 130,921 | ||
| Cost of goods sold | 107,952 | 82,836 | ||||
| Gross profit | 71,813 | 48,085 | ||||
| Operating expenses | ||||||
| Selling, general and administrative | 38,231 | 28,792 | ||||
| Income from operations | 33,582 | 19,293 | ||||
| Other income (expense) | ||||||
| Unrealized gain on derivative instruments | 2,827 | 2,817 | ||||
| Foreign currency (loss) gain | (499 | ) | 580 | |||
| Interest income | 1,561 | 1,518 | ||||
| Other (expense) income | (29 | ) | 155 | |||
| Total other income | 3,860 | 5,070 | ||||
| Income before income taxes | 37,442 | 24,363 | ||||
| Income tax expense | 6,968 | 5,481 | ||||
| Net income | $ | 30,474 | $ | 18,882 | ||
| Net income attributable to The | ||||||
| Basic | $ | 0.53 | $ | 0.33 | ||
| Diluted | $ | 0.50 | $ | 0.31 | ||
| Weighted-average number of common shares outstanding | ||||||
| Basic | 57,114,475 | 56,994,146 | ||||
| Diluted | 60,471,324 | 59,975,827 | ||||
| THE CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Amounts in thousands) | |||||||
| Three Months Ended | |||||||
| 2026 | 2025 | ||||||
| Cash flows from operating activities: | |||||||
| Net income | $ | 30,474 | $ | 18,882 | |||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
| Depreciation and amortization | 476 | 202 | |||||
| Amortization of debt issuance cost | 5 | — | |||||
| (Decrease) increase of provision for credit losses | (384 | ) | 434 | ||||
| Unrealized gain on derivative instruments | (2,827 | ) | (2,817 | ) | |||
| Stock-based compensation | 4,626 | 2,186 | |||||
| Noncash lease expense | 633 | 504 | |||||
| Changes in operating assets and liabilities: | |||||||
| Accounts receivable | (39,444 | ) | (13,150 | ) | |||
| Inventory | 24,815 | (4,508 | ) | ||||
| Prepaid expenses, net supplier advances, and other assets | (6,536 | ) | (2,583 | ) | |||
| Accounts payable, accrued expenses, and other liabilities | 3,762 | (8,950 | ) | ||||
| Net cash provided by/(used in) operating activities | 15,600 | (9,800 | ) | ||||
| Cash flows from investing activities: | |||||||
| Cash paid for property and equipment | (461 | ) | (559 | ) | |||
| Net cash used in investing activities | (461 | ) | (559 | ) | |||
| Cash flows from financing activities: | |||||||
| Proceeds from exercise of stock awards | 1,606 | 404 | |||||
| Cash paid on notes payable | (3 | ) | (2 | ) | |||
| Cash paid to acquire treasury stock | (11,505 | ) | (1,501 | ) | |||
| Net cash used in financing activities | (9,902 | ) | (1,099 | ) | |||
| Effects of exchange rate changes on cash and cash equivalents | (195 | ) | 401 | ||||
| Net increase/(decrease) in cash and cash equivalents | 5,042 | (11,057 | ) | ||||
| Cash, cash equivalents and restricted cash at beginning of the period (1) | 198,154 | 165,933 | |||||
| Cash, cash equivalents and restricted cash at end of the period (1) | $ | 203,196 | 154,876 | ||||
1 Includes
RECONCILIATION FROM GAAP NET INCOME TO NON-GAAP ADJUSTED EBITDA
| Three Months Ended | |||||||
| 2026 | 2025 | ||||||
| (in thousands) | |||||||
| Net income | 30,474 | 18,882 | |||||
| Depreciation and amortization | 476 | 202 | |||||
| Interest income | (1,561 | ) | (1,518 | ) | |||
| Income tax expense | 6,968 | 5,481 | |||||
| EBITDA | $ | 36,357 | $ | 23,047 | |||
| Stock-based compensation (a) | 4,626 | 2,186 | |||||
| Unrealized (gain) on derivative instruments (b) | (2,827 | ) | (2,817 | ) | |||
| Foreign currency loss/(gain) (b) | 499 | (580 | ) | ||||
| Other adjustments (c) | — | 669 | |||||
| Adjusted EBITDA | $ | 38,655 | $ | 22,505 | |||
| (a) | Non-cash charges related to stock-based compensation, which vary from period to period depending on volume and vesting timing of awards and forfeitures. We adjusted for these charges to facilitate comparison from period to period. |
| (b) | Unrealized gains or losses on derivative instruments and foreign currency gains or losses are not considered in our evaluation of our ongoing performance. |
| (c) | The three months ended |
SUPPLEMENTAL INFORMATION
| Three Months Ended | |||||
| (in thousands) | 2026 | 2025 | |||
| Vita Coco Coconut Water | $ | 118,033 | $ | 86,118 | |
| Private Label | 24,400 | 21,197 | |||
| Other | 5,731 | 5,285 | |||
| Subtotal | $ | 148,164 | $ | 112,600 | |
| International segment | |||||
| Vita Coco Coconut Water | $ | 22,520 | $ | 13,177 | |
| Private Label | 8,837 | 4,759 | |||
| Other | 244 | 385 | |||
| Subtotal | $ | 31,601 | $ | 18,321 | |
| Total net sales | $ | 179,765 | $ | 130,921 | |
| COST OF GOODS SOLD & GROSS PROFIT | |||||||
| Three Months Ended | |||||||
| (in thousands) | 2026 | 2025 | |||||
| Cost of goods sold | |||||||
| $ | 87,230 | $ | 70,288 | ||||
| International segment | 20,722 | 12,548 | |||||
| Total cost of goods sold | $ | 107,952 | $ | 82,836 | |||
| Gross profit | |||||||
| $ | 60,934 | $ | 42,312 | ||||
| International segment | 10,879 | 5,773 | |||||
| Total gross profit | $ | 71,813 | $ | 48,085 | |||
| Gross margin | |||||||
| 41.1 | % | 37.6 | % | ||||
| International segment | 34.4 | % | 31.5 | % | |||
| Consolidated | 39.9 | % | 36.7 | % | |||
| VOLUME (CE) | ||||||||
| Percentage Change - Three Months Ended | ||||||||
| International segment | Total | |||||||
| Vita Coco Coconut Water | 29.4 | % | 45.1 | % | 32.0 | % | ||
| Private Label | 17.6 | % | 61.8 | % | 27.3 | % | ||
| Other | 14.7 | % | 44.5 | % | 15.6 | % | ||
| Subtotal | 26.0 | % | 50.2 | % | 30.2 | % | ||
Note: A CE is a standard volume measure used by management which is defined as a case of 12 bottles of 330ml liquid beverages or the same liter volume of oil. We may have immaterial sales of raw materials at times that are treated as zero CEs for the purposes of these calculations.
Source: The 